Abstract
Summary:
In this issue of Blood Cancer Discovery, Chesi and colleagues have performed a series of mouse experiments, combined with patient sample analysis, to delineate the role of del(13) in multiple myeloma. They identify loss of the miRNA cluster MIR15A/16-1 as critical for myelomagenesis and progression of disease.
See related article by Chesi et al., p. 68.
©2020 American Association for Cancer Research.
2020
American Association for Cancer Research.
You do not currently have access to this content.